Compare COHR & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COHR | HLN |
|---|---|---|
| Founded | 1971 | 2022 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Electronic Components | Package Goods/Cosmetics |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.2B | 43.7B |
| IPO Year | 1995 | N/A |
| Metric | COHR | HLN |
|---|---|---|
| Price | $247.21 | $10.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 1 |
| Target Price | ★ $214.25 | N/A |
| AVG Volume (30 Days) | 5.4M | ★ 8.0M |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.81% |
| EPS Growth | ★ 71.74 | N/A |
| EPS | ★ 1.95 | N/A |
| Revenue | ★ $1,158,794,000.00 | N/A |
| Revenue This Year | $21.62 | $7.04 |
| Revenue Next Year | $23.75 | $4.58 |
| P/E Ratio | $128.56 | ★ $49.05 |
| Revenue Growth | ★ 19.21 | N/A |
| 52 Week Low | $45.58 | $8.71 |
| 52 Week High | $300.20 | $11.42 |
| Indicator | COHR | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 50.30 | 38.43 |
| Support Level | $170.95 | $9.48 |
| Resistance Level | $247.15 | $10.31 |
| Average True Range (ATR) | 19.59 | 0.16 |
| MACD | -3.21 | -0.12 |
| Stochastic Oscillator | 20.13 | 11.29 |
Coherent Corp engaged in materials, networking, and lasers, is a vertically integrated manufacturing company that develops, manufactures, and markets engineered materials, optoelectronic components and devices, and lasers for use in the industrial, communications, electronics and instrumentation markets. The firm operates in three segments Networking, Materials, and Lasers Segment. It generates maximum revenue from Networking segment. The company geographically operates in North America. Europe, China, Japan and Rest of the world.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.